Stocks›Healthcare›PEN

PEN Penumbra, Inc

NYSEResearch view

Penumbra, Inc operates in the Surgical & Medical Instruments & Apparatus industry.

$320.86−0.11%
Oct 16 close · 1D EOD · Databento
HealthcareSurgical & Medical Instruments & ApparatusLarge-capSEC EDGAR FY 2025-12-31

On the WireNo stories on PEN yet. Follow the company and the next one lands in Following.

The numbers · FY2025, filed

SEC EDGAR
Market cap$12.6B
Revenue$1.4B+17.50%
Net income$177.7M
EPS, diluted$4.52+1155.60%
Gross margin67.1%
Operating margin13.5%
All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31
SectorHealthcare
Market Cap$12.6B
Enterprise Value$12.5B
Income$177.7M
Sales$1.4B
Book/sh$36.24
Cash/sh$4.74
Dividend TTM—
Payout—
Employees—
IPO—
Quick Ratio4.29
Current Ratio6.64
Debt/Eq—
EPS (ttm)$4.52
EPS this Y1155.6%
EPS past 3/5Y—
Sales past 3/5Y18.3%
EPS Y/Y TTM1155.6%
Sales Y/Y TTM17.5%
Shs Outstand39.39M
ROA9.7%
ROE12.4%
ROIC13.2%
Gross Margin67.1%
Oper. Margin13.5%
Profit Margin12.7%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$747.6M
FY21
$847.1M
FY22
$1.1B
FY23
$1.2B
FY24
$1.4B
FY25

Operating leverage — margins

GrossOperatingNet
0%40%80%67%13%13%FY21FY22FY23FY24FY25
Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it
USDFY2021FY2022FY2023FY2024FY2025

Same industry

In the screener →

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.